Differences in drug efficacy and prognosis between primary and metastatic sites for de novo stage IV breast cancer: an exploratory analysis of a phase III trial, JCOG1017
Breast Cancer · 2026-07 · 33 (4) · 829-838
DOI: 10.1007/s12282-026-01846-3 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Breast Cancer, online erschienen am 16.04.2026. Verfasst von Kiyo Tanaka und 21 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast Surgery, Toranomon Hospital, 2-2-2 Toranomon, Minato-ku, Tokyo, 105-8470, Japan. Hauptthemen laut MEDLINE: Antineoplastic Combined Chemotherapy Protocols, Breast Neoplasms. Die Arbeit nennt 8 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Okayama University.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Breast Surgery, Toranomon Hospital, 2-2-2 Toranomon, Minato-ku, Tokyo, 105-8470, Japan.
- Department of Breast and Medical Oncology, National Center for Global Health and Medicine, Tokyo, Japan.
- Department of Breast Surgery, Osaka Habikino Medical Center, Osaka, Japan.
- Department of Breast Surgery, Kanagawa Cancer Center, Kanagawa, Japan.
- Department of Breast and Endocrine Surgery, Okayama University Hospital, Okayama, Japan.
- Department of Advanced Clinical Research and Development, Nagoya City University Graduate School of Medical Sciences, Nagoya , Aichi, Japan.
Förderung
- Okayama University
Zitieren
APA
Tanaka, K., Shimomura, A., Ishitobi, M., Yamanaka, T., Tsukioki, T., Iwata, H., Hara, F., Fujisawa, T., Sasaki, K., Sadachi, R., Kajikawa, R., Sakai, T., Sagara, Y., Shigematsu, H., Ozaki, Y., Nozawa, K., Sudo, K., Naito, Y., Terata, K., …, & Shien, T. (2026). Differences in drug efficacy and prognosis between primary and metastatic sites for de novo stage IV breast cancer: an exploratory analysis of a phase III trial, JCOG1017. Breast Cancer, 33(4), 829-838. https://doi.org/10.1007/s12282-026-01846-3
Vancouver
Tanaka K, Shimomura A, Ishitobi M, Yamanaka T, Tsukioki T, Iwata H, et al. Differences in drug efficacy and prognosis between primary and metastatic sites for de novo stage IV breast cancer: an exploratory analysis of a phase III trial, JCOG1017. Breast Cancer. 2026;33(4):829-838. doi:10.1007/s12282-026-01846-3
BibTeX
@article{Tanaka2026,
author = {Tanaka, Kiyo and Shimomura, Akihiko and Ishitobi, Makoto and Yamanaka, Takashi and Tsukioki, Takahiro and Iwata, Hiroji and Hara, Fumikata and Fujisawa, Tomomi and Sasaki, Keita and Sadachi, Ryo and Kajikawa, Riku and Sakai, Takehiko and Sagara, Yasuaki and Shigematsu, Hideo and Ozaki, Yukinori and Nozawa, Kazuki and Sudo, Kazuki and Naito, Yoichi and Terata, Kaori and Ishiba, Toshiyuki and Fukuda, Haruhiko and Shien, Tadahiko},
title = {Differences in drug efficacy and prognosis between primary and metastatic sites for de novo stage IV breast cancer: an exploratory analysis of a phase III trial, JCOG1017},
journal = {Breast Cancer},
year = {2026},
volume = {33},
number = {4},
pages = {829--838},
doi = {10.1007/s12282-026-01846-3}
}
EUVIMED